| Dr Karen Paczkowski, MD | |
|
300 Lackawanna Ave, Scranton, PA 18503-2001 | |
| (570) 342-7864 | |
| Not Available |
| Full Name | Dr Karen Paczkowski |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 46 Years |
| Location | 300 Lackawanna Ave, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326000290 | NPI | - | NPPES |
| 0009057210007 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Traditional Home Health Care | Dunmore, PA | Home health agency |
| Allied Services Home Health | Clarks summit, PA | Home health agency |
| Interim Healthcare Services Of Ne Pa, Inc. | Blakely, PA | Home health agency |
| Commonwealth Home Health Of Moses Taylor | Scranton, PA | Home health agency |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Regional Hospital Of Scranton | Scranton, PA | Hospital |
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steffie Enterprises, Inc | 0840225736 | 354 |
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave.
Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients.
› Verified 1 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave.
Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients.
› Verified 1 days ago
| Entity Name | Delta Medix Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396701876 PECOS PAC ID: 0648162636 Enrollment ID: O20040325001062 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave.
Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients.
› Verified 1 days ago
| Entity Name | Scranton Quincy Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508143074 PECOS PAC ID: 0143487389 Enrollment ID: O20120131000544 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave.
Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Paczkowski, MD 2100 Mack Blvd, Allentown, PA 18103-5622 Ph: (484) 884-0617 | Dr Karen Paczkowski, MD 300 Lackawanna Ave, Scranton, PA 18503-2001 Ph: (570) 342-7864 |
News Archive
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. FIK designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
As many as 16.8 million Americans had undiagnosed SARS-CoV-2 infections - 5 times the rate of diagnosed infections - by the end of July of 2020, according to an analysis of antibodies from more than 8,000 previously undiagnosed adults collected during the pandemic's first wave.
Women and minorities, particularly African Americans, continue to be inadequately represented in clinical trials for novel cardiometabolic medications, with no evidence of improvement in enrollment numbers over the past decade, according to new research published last week in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in HER2+ breast cancer patients.
› Verified 1 days ago
Dr. Ivan Cvorovic, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 S Washington Ave Ste 1000, Scranton, PA 18505 Phone: 570-343-2383 | |
Ritu Khurana, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7351 Fax: 570-703-7801 | |
Dr. Titilayo O Osuntokun, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 959 Wyoming Ave, Scranton, PA 18509 Phone: 570-344-3517 Fax: 570-344-6839 | |
Nalini G Kakimallaiah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Quincy Ave, Hospitalist Office, Scranton, PA 18510 Phone: 866-519-0457 Fax: 570-770-5263 | |
Dr. Joseph Frank Leo, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Fouzia Oza, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 700 Quincy Ave, Scranton, PA 18510 Phone: 570-770-5000 | |
John P Lundin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 746 Jefferson Ave, Suite 305, Scranton, PA 18510 Phone: 570-342-1776 Fax: 570-963-0663 |